Organic Process Research & Development · 2002 · 20 citations · 24 references
PharmacyBiochemistryMedicinal ChemistryDrug DiscoveryNatural Product BiosynthesisProdrug DesignVitamin BiochemistryVitamin ChemistryVitamin DVitamin D DisordersVitamin D MetabolismVitamin MetabolismStereospecific ReactionsVitamin D AnalogsVitamin D AnaloguesVitamin D BiosynthesisVitamin D MetabolitesVitamin D Synthesis
This contribution describes the first stereospecific synthesis of 24( S )-hydroxyvitamin D 2 ( 1 ), a metabolite of vitamin D 2 . This metabolite acts as a prodrug for 1α,24( S )-dihydroxyvitamin D 2 ( 2 ), which is under development for treatment of various diseases characterized by cellular hyperproliferation. The key step of the synthesis involves the Wittig−Horner olefination of ( S )-2,3-dimethyl-2-triethysilyloxybutyraldehyde ( 17 ) and a vitamin D 2 phosphine oxide derivative ( 22 ). The synthesis of the requisite aldehyde started with the commercially available l -(+)-valine and was completed in seven steps. The vitamin D 2 phosphine oxide derivative was synthesized in seven steps starting from vitamin D 2 .
24
Total synthesis of the macrolide antibiotic cytovaricin
David A. Evans, Stephen W. Kaldor, Todd K. Jones et al. · Journal of the American Chemical Society · 1990 · 312 citations